Home Biotechnology Galimedix Therapeutics, Inc.
G

Galimedix Therapeutics, Inc.

Profile managed by Bizz Id

Galimedix Therapeutics

United States 1-10 employees
Biotechnology
Claim this profile

Description

Phase 2 clinical-stage biopharmaceutical company developing innovative treatments for neurodegenerative eye diseases such as dry age-related macular degeneration (AMD) and glaucoma, with candidate GAL-101 in partnership with Théa Open Innovation.

Contact company

Register for free to see this company’s contact details and get in touch.

Register - Free

We only use technical cookies that are necessary for the site to work and to keep you signed in. We do not use analytics or advertising cookies. Cookies